BRLF1 Polyclonal Antibody, FITC Conjugated
Product Specifications
Background
Immediate-early transcription factor that controls the initiation of viral lytic gene expression and lytic reactivation from latency. Triggers lytic replication, and initiates a cellular senescence program in epithelial cells. Upregulates human DCR3/TNFRSF6B by directly binding to its receptor.
Synonyms
Human herpesvirus 4 type 2
Swiss Prot
Q3KSS7
Host
Rabbit
Cross Reactivity
Human, Virus
Immunogen
151-250/605
Target
BRLF1
Clonality
Polyclonal
Isotype
IgG
Conjugation
FITC
Source
KLH conjugated synthetic peptide derived from human HHV4tp2 BRLF1
Applications
IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
1µg/µl
Dilution
IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Product Datasheet
https://www.biossantibodies.com/datasheets/bs-4500R-FITC
Cross Reactivity Details
HHV4tp2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7010521-01 0.02 mg
Recombinant Human UPF0694 transmembrane protein C14orf109 (C14orf109)
Ask
View Details MBS7010521-02 0.1 mg
Recombinant Human UPF0694 transmembrane protein C14orf109 (C14orf109)
Ask
View Details MBS7010521-03 5x 0.1 mg
Recombinant Human UPF0694 transmembrane protein C14orf109 (C14orf109)
Ask
View Details